GIP Protein, Mouse, Recombinant (hFc)

SKU TMPK-00890-100 μg Category Recombinant-Protein Brand: TargetMol

Price range: 669 CAD through 2,672 CAD

Size

100 μg 500 μg

Clear

Products Details

Product Description

– The potential application of glucose-dependent insulinotropic polypeptide (gastric inhibitory polypeptide, GIP) in the management of obesity and type 2 diabetes has been controversial. Initial interest in the therapeutic use of GIP was dampened by evidence that its insulinotropic activity was reduced in type 2 diabetes and by reports that it increased glucagon secretion and adipose deposition in non-diabetic individuals. GIP Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with C-hFc tag. The predicted molecular weight is 34.3 kDa and the accession number is P48756.

For Research Use Only (RUO). This product is sold strictly for laboratory research use only. Not for human or veterinary consumption, therapeutic, or diagnostic use. Any pharmacological, therapeutic, cosmetic, or biological effects described above are provided as research context only and do not represent intended or approved uses of this product.

Web ID

– TMPK-00890

Storage Temperature

– -20℃

Shipping

– Blue Ice

References

– Bailey CJ. GIP analogues and the treatment of obesity-diabetes. Peptides. 2020 Mar;125:170202. doi: 10.1016/j.peptides.2019.170202. Epub 2019 Nov 19. PMID: 31756366.

Molecular Weight

Product type

– Recombinant-Protein

Booklet

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.